TrialClinical infectious diseases : an official publication of the Infectious Diseases Society of America2022

Efficacy and Safety of Switching to Dolutegravir/Lamivudine Versus Continuing a Tenofovir Alafenamide-Based 3- or 4-Drug Regimen for Maintenance of Virologic Suppression in Adults Living With Human Immunodeficiency Virus Type 1: Results Through Week 144 From the Phase 3, Noninferiority TANGO Randomized Trial.

Olayemi Osiyemi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.